Skip to content
AdminJun 16, 2021< 1 min read

Experiences Implementing Data Synthesis in a Global Life Sciences Company

2021-06-16-Experiences-Implementing-1

Stephen Bamford, Head of Clinical Data Standards & Transparency; IDAR, Global Development, Janssen

A webinar from Stephen Bamford at Janssen describing their experiences with the implementation of synthetic data generation and where it fits in among other PETs.

 

 

Following the acquisition of Replica Analytics by Aetion, the generative AI technology previously known as Replica Synthesis is now Aetion® Generate and continues to create privacy-enhancing synthetic data.
Learn More

RELATED ARTICLES

Natalie Schibell, MPHDec 17, 20244 min read

Aetion Generate 3.6: Privacy Meets Scientific Rigor in Real-World Evidence

At Aetion®, we ensure privacy concerns and compliance hurdles never stand in the way of transforming sensitive data into ...
Start Reading
Natalie Schibell, MPHDec 17, 20244 min read

Feature Spotlight: Transforming RWD Management with Measures Assistant (Beta)

Real-world data (RWD) is the lifeblood of modern healthcare research, driving advancements in understanding and treatment. Yet, ...
Start Reading
AdminDec 10, 20242 min read

FDA Expands Dupixent Approval for Adolescents with Chronic Rhinosinusitis with Nasal Polyps, Leveraging RWE Powered by Aetion® Substantiate

Blog authored by:
Start Reading